Malignant Liver Neoplasm — Trials

Malignant Liver Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

4,123 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 908
Recruiting: 530
Ph III recruiting: 46
Growth YoY: +5.9%
Industry share: 20%
Top sponsor: Sun Yat-sen University
Termination share: 32.5%
Trials / 1,000 deaths: 30.4 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (459)

clinicaltrialsPublishedShowing 451–456 of 456 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00534664	Phase I/II Study of Amplitude-Modulated Electromagnetic Fields in the Treatment of Advanced Hepatocellular Carcinoma(TheraBionic)	completed	Phase 1 / Phase 2	40	University of Sao PauloOTHER	1	Sep 26, 2007	clinicaltrials
NCT00076609	Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma	completed	Phase 1 / Phase 2	31	PhytoCeuticaINDUSTRY	2	Mar 28, 2007